{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:12:33Z","timestamp":1757617953304,"version":"3.44.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00277-025-06322-0","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T01:40:42Z","timestamp":1746495642000},"page":"3511-3516","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Germline mutations predispose a concurrent thymoma and diffuse large B-cell lymphoma"],"prefix":"10.1007","volume":"104","author":[{"given":"Xiaoyan","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"6322_CR1","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.2217\/fon-2017-0626","volume":"14","author":"V Kumar","year":"2018","unstructured":"Kumar V, Garg M, Goyal A et al (2018) Changing pattern of secondary cancers among patients with malignant thymoma in the USA. Future Oncol Lond Engl 14:1943\u20131951","journal-title":"Future Oncol Lond Engl"},{"key":"6322_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/ejcts\/ezs663","volume":"44","author":"PL Filosso","year":"2013","unstructured":"Filosso PL, Galassi C, Ruffini E et al (2013) Thymoma and the increased risk of developing extrathymic malignancies: a multicentre study. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg 44:219\u2013224 discussion 224","journal-title":"Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg"},{"key":"6322_CR3","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1002\/1097-0142(20011101)92:9<2406::AID-CNCR1589>3.0.CO;2-7","volume":"92","author":"CC Pan","year":"2001","unstructured":"Pan CC, Chen PC, Wang LS et al (2001) Thymoma is associated with an increased risk of second malignancy. Cancer 92:2406\u20132411","journal-title":"Cancer"},{"key":"6322_CR4","first-page":"S260","volume":"5","author":"EA Engels","year":"2010","unstructured":"Engels EA (2010) Epidemiology of thymoma and associated malignancies. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 5:S260\u2013265","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"6322_CR5","doi-asserted-by":"publisher","first-page":"100502","DOI":"10.1016\/j.currproblcancer.2019.100502","volume":"44","author":"S Jiang","year":"2020","unstructured":"Jiang S, Zhen H, Jiang H (2020) Second primary malignancy in diffuse large B-cell lymphoma patients: A SEER database analysis. Curr Probl Cancer 44:100502","journal-title":"Curr Probl Cancer"},{"key":"6322_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jns.2009.11.006","volume":"290","author":"JF Owe","year":"2010","unstructured":"Owe JF, Cvancarova M, Romi F et al (2010) Extrathymic malignancies in thymoma patients with and without myasthenia Gravis. J Neurol Sci 290:66\u201369","journal-title":"J Neurol Sci"},{"key":"6322_CR7","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/00000658-199910000-00012","volume":"230","author":"KB Wilkins","year":"1999","unstructured":"Wilkins KB, Sheikh E, Green R et al (1999) Clinical and pathologic predictors of survival in patients with thymoma. Ann Surg 230:562\u2013572 discussion 572\u2013574","journal-title":"Ann Surg"},{"key":"6322_CR8","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1002\/ijc.25583","volume":"128","author":"SM Gadalla","year":"2011","unstructured":"Gadalla SM, Rajan A, Pfeiffer R et al (2011) A population-based assessment of mortality and morbidity patterns among patients with thymoma. Int J Cancer 128:2688\u20132694","journal-title":"Int J Cancer"},{"key":"6322_CR9","first-page":"576","volume":"24","author":"T Kamata","year":"2017","unstructured":"Kamata T, Yoshida S, Wada H et al (2017) Extrathymic malignancies associated with thymoma: a forty-year experience at a single institution. Interact Cardiovasc Thorac Surg 24:576\u2013581","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"6322_CR10","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1093\/annonc\/mdh155","volume":"15","author":"A Evoli","year":"2004","unstructured":"Evoli A, Punzi C, Marsili F et al (2004) Extrathymic malignancies in patients with thymoma. Ann Oncol Off J Eur Soc Med Oncol 15:692\u2013693","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"6322_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/icvts\/ivy260","volume":"28","author":"M Hamaji","year":"2019","unstructured":"Hamaji M, Kawaguchi A, Omasa M et al (2019) Low incidence of and mortality from a second malignancy after resection of thymic carcinoma\u2020. Interact Cardiovasc Thorac Surg 28:375\u2013379","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"6322_CR12","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ijc.11099","volume":"105","author":"EA Engels","year":"2003","unstructured":"Engels EA, Pfeiffer RM (2003) Malignant thymoma in the united States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 105:546\u2013551","journal-title":"Int J Cancer"},{"key":"6322_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/1010-7940(94)90155-4","volume":"8","author":"A Masaoka","year":"1994","unstructured":"Masaoka A, Yamakawa Y, Niwa H et al (1994) Thymectomy and malignancy. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg 8:251\u2013253","journal-title":"Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg"},{"key":"6322_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.athoracsur.2010.09.025","volume":"91","author":"Y-T Yen","year":"2011","unstructured":"Yen Y-T, Lai W-W, Wu M-H et al (2011) Thymic neuroendocrine carcinoma and thymoma are both associated with increased risk of extrathymic malignancy: a 20-year review of a single institution. Ann Thorac Surg 91:219\u2013225","journal-title":"Ann Thorac Surg"},{"key":"6322_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ssu.2980060209","volume":"6","author":"MM Couture","year":"1990","unstructured":"Couture MM, Mountain CF, Thymoma (1990) Semin Surg Oncol 6:110\u2013114","journal-title":"Semin Surg Oncol"},{"key":"6322_CR16","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1002\/1097-0142(196811)22:6<1221::AID-CNCR2820220619>3.0.CO;2-7","volume":"22","author":"JV Souadjian","year":"1968","unstructured":"Souadjian JV, Silverstein MN, Titus JL (1968) Thymoma and cancer. Cancer 22:1221\u20131225","journal-title":"Cancer"},{"key":"6322_CR17","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.3109\/10428194.2013.792927","volume":"54","author":"V Ertel","year":"2013","unstructured":"Ertel V, Fr\u00fch M, Guenther A et al (2013) Thymoma with molecularly verified \u2018conversion\u2019 to T lymphoblastic leukemia\/lymphoma over 9 years. Leuk Lymphoma 54:2765\u20132768","journal-title":"Leuk Lymphoma"},{"key":"6322_CR18","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1080\/10428194.2018.1520993","volume":"60","author":"Q Le Clef","year":"2019","unstructured":"Le Clef Q, Ortega-Sanchez G, Dirnhofer S et al (2019) T-lymphoblastic lymphoma after previous thymoma: how NGS helps Establishing the diagnosis and procures new insights. Leuk Lymphoma 60:1320\u20131323","journal-title":"Leuk Lymphoma"},{"key":"6322_CR19","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1080\/15384101.2018.1450029","volume":"17","author":"L Sim\u00f3n-Carrasco","year":"2018","unstructured":"Sim\u00f3n-Carrasco L, Jim\u00e9nez G, Barbacid M et al (2018) The capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer. Cell Cycle Georget Tex 17:702\u2013711","journal-title":"Cell Cycle Georget Tex"},{"key":"6322_CR20","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1101\/gad.300244.117","volume":"31","author":"L Sim\u00f3n-Carrasco","year":"2017","unstructured":"Sim\u00f3n-Carrasco L, Gra\u00f1a O, Salm\u00f3n M et al (2017) Inactivation of capicua in adult mice causes T-cell lymphoblastic lymphoma. Genes Dev 31:1456\u20131468","journal-title":"Genes Dev"},{"key":"6322_CR21","doi-asserted-by":"publisher","first-page":"e532","DOI":"10.1038\/bcj.2017.15","volume":"7","author":"OC Leeksma","year":"2017","unstructured":"Leeksma OC, de Miranda NF, Veelken H (2017) Germline mutations predisposing to diffuse large B-cell lymphoma. Blood Cancer J 7:e532","journal-title":"Blood Cancer J"},{"key":"6322_CR22","first-page":"2489","volume":"6","author":"H-P Kuo","year":"2016","unstructured":"Kuo H-P, Ezell SA, Hsieh S et al (2016) The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma. Am J Cancer Res 6:2489\u20132501","journal-title":"Am J Cancer Res"},{"key":"6322_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1182\/blood-2011-01-330795","volume":"118","author":"I Salaverria","year":"2011","unstructured":"Salaverria I, Philipp C, Oschlies I et al (2011) Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. Blood 118:139\u2013147","journal-title":"Blood"},{"key":"6322_CR24","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1056\/NEJMoa1508054","volume":"373","author":"J Zhang","year":"2015","unstructured":"Zhang J, Walsh MF, Wu G et al (2015) Germline mutations in predisposition genes in pediatric cancer. N Engl J Med 373:2336\u20132346","journal-title":"N Engl J Med"},{"key":"6322_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cell.2018.03.039","volume":"173","author":"K-L Huang","year":"2018","unstructured":"Huang K-L, Mashl RJ, Wu Y et al (2018) Pathogenic germline variants in 10,389 adult cancers. Cell 173:355\u2013370e14","journal-title":"Cell"},{"key":"6322_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41568-020-00315-z","volume":"21","author":"JM Klco","year":"2021","unstructured":"Klco JM, Mullighan CG (2021) Advances in germline predisposition to acute leukaemias and myeloid neoplasms. Nat Rev Cancer 21:122\u2013137","journal-title":"Nat Rev Cancer"},{"key":"6322_CR27","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S1074-7613(03)00148-1","volume":"18","author":"H Hara","year":"2003","unstructured":"Hara H, Wada T, Bakal C et al (2003) The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity 18:763\u2013775","journal-title":"Immunity"},{"key":"6322_CR28","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41586-018-0290-0","volume":"560","author":"JD Phelan","year":"2018","unstructured":"Phelan JD, Young RM, Webster DE et al (2018) A multiprotein supercomplex controlling oncogenic signalling in lymphoma. Nature 560:387\u2013391","journal-title":"Nature"},{"key":"6322_CR29","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1084\/jem.20120831","volume":"209","author":"AL Snow","year":"2012","unstructured":"Snow AL, Xiao W, Stinson JR et al (2012) Congenital B cell lymphocytosis explained by novel germline CARD11 mutations. J Exp Med 209:2247\u20132261","journal-title":"J Exp Med"},{"key":"6322_CR30","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.jaci.2018.08.013","volume":"143","author":"B Dorjbal","year":"2019","unstructured":"Dorjbal B, Stinson JR, Ma CA et al (2019) Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse Immunologic phenotypes with or without atopic disease. J Allergy Clin Immunol 143:1482\u20131495","journal-title":"J Allergy Clin Immunol"},{"key":"6322_CR31","doi-asserted-by":"publisher","DOI":"10.4267\/2042\/44857","author":"N Dagoneau","year":"2011","unstructured":"Dagoneau N, Cormier-Daire V (2011) LIFR (leukemia inhibitory factor receptor alpha). Atlas genet cytogenet oncol haematol. Epub ahead Print November. https:\/\/doi.org\/10.4267\/2042\/44857","journal-title":"Epub ahead Print November"},{"key":"6322_CR32","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/378298a0","volume":"378","author":"M Turner","year":"1995","unstructured":"Turner M, Mee PJ, Costello PS et al (1995) Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 378:298\u2013302","journal-title":"Nature"},{"key":"6322_CR33","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.bbamcr.2009.03.004","volume":"1793","author":"RL Geahlen","year":"2009","unstructured":"Geahlen RL (2009) Syk and pTyr\u2019d: signaling through the B cell antigen receptor. Biochim Biophys Acta 1793:1115\u20131127","journal-title":"Biochim Biophys Acta"},{"key":"6322_CR34","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1182\/blood-2004-10-3898","volume":"106","author":"E Ruiz-Ballesteros","year":"2005","unstructured":"Ruiz-Ballesteros E, Mollejo M, Rodriguez A et al (2005) Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis. Blood 106:1831\u20131838","journal-title":"Blood"},{"key":"6322_CR35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2141.2005.05883.x","volume":"132","author":"A Rinaldi","year":"2006","unstructured":"Rinaldi A, Kwee I, Taborelli M et al (2006) Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma. Br J Haematol 132:303\u2013316","journal-title":"Br J Haematol"},{"key":"6322_CR36","doi-asserted-by":"publisher","first-page":"6342","DOI":"10.1182\/blood-2011-02-333773","volume":"118","author":"S Cheng","year":"2011","unstructured":"Cheng S, Coffey G, Zhang XH et al (2011) SYK Inhibition and response prediction in diffuse large B-cell lymphoma. Blood 118:6342\u20136352","journal-title":"Blood"},{"key":"6322_CR37","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.1182\/blood-2006-05-026203","volume":"108","author":"L Leseux","year":"2006","unstructured":"Leseux L, Hamdi SM, Al Saati T et al (2006) Syk-dependent mTOR activation in follicular lymphoma cells. Blood 108:4156\u20134162","journal-title":"Blood"},{"key":"6322_CR38","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1182\/blood-2009-08-236471","volume":"115","author":"JW Friedberg","year":"2010","unstructured":"Friedberg JW, Sharman J, Sweetenham J et al (2010) Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia. Blood 115:2578\u20132585","journal-title":"Blood"},{"key":"6322_CR39","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1038\/leu.2016.135","volume":"30","author":"D Juskevicius","year":"2016","unstructured":"Juskevicius D, Lorber T, Gsponer J et al (2016) Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis. Leukemia 30:2385\u20132395","journal-title":"Leukemia"},{"key":"6322_CR40","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/ijc.28988","volume":"135","author":"C Cybulski","year":"2014","unstructured":"Cybulski C, Nazarali S, Narod SA (2014) Multiple primary cancers as a guide to heritability. Int J Cancer 135:1756\u20131763","journal-title":"Int J Cancer"},{"key":"6322_CR41","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1615\/CritRevImmunol.2017018916","volume":"36","author":"P Christopoulos","year":"2016","unstructured":"Christopoulos P, Fisch P (2016) Acquired T-Cell immunodeficiency in thymoma patients. Crit Rev Immunol 36:315\u2013327","journal-title":"Crit Rev Immunol"},{"key":"6322_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/ejh.13082","volume":"101","author":"A Meister","year":"2018","unstructured":"Meister A, Hentrich M, Wyen C et al (2018) Malignant lymphoma in the HIV-positive patient. Eur J Haematol 101:119\u2013126","journal-title":"Eur J Haematol"},{"key":"6322_CR43","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","volume":"111","author":"K Ekstr\u00f6m Smedby","year":"2008","unstructured":"Ekstr\u00f6m Smedby K, Vajdic CM, Falster M et al (2008) Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the interlymph consortium. Blood 111:4029\u20134038","journal-title":"Blood"},{"key":"6322_CR44","doi-asserted-by":"crossref","unstructured":"Cioroianu AI, Stinga PI, Sticlaru L et al (2019) Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis. Anal Cell Pathol Amst. 2019:8586354","DOI":"10.1155\/2019\/8586354"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06322-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06322-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06322-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T13:24:25Z","timestamp":1757165065000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06322-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["6322"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06322-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"23 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of the First Hospital of China Medical University(#AF-SOP-07-1.0-01). Written informed consent was signed by the patient in advance.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent for publication of the clinical details and images was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}